It stresses the similarities between ANCA +ve and ANCA −ve cases and supports the notion that pauci-
the study period. Previous studies of pauci-immune RPGN ( Table 1) have concentrated on ANCA positive (+ve) cases [4, [8] [9] [10] [11] [12] [13] [14] 21] . Because of selection bias due to referral patterns most of these studies do not allow derivation of incidence rates. The one that does [15] studied patients presenting to rheumatologists, only a proportion of whom had renal disease. This paper presents information on the incidence, clinical features and outcome of pauci-immune RPGN irrespective of the ANCA status from a defined population over a 10-year period. It compares characteristics and outcomes of ANCA +ve and −ve cases. We also present a group of patients receiving renal transplants with this condition, an area that has received little attention previously.
Subjects and methods
We retrospectively reviewed all patients with pauci-immune RPGN who presented to a large regional renal unit over a 10-year period, from April 1986 to April 1996, during which ANCA serology was routinely performed. We defined the catchment area using the 1993 National Renal Review which collected data on the geographical location of all patients accepted onto renal replacement programmes in [1991] [1992] in England. The denominator population was the mid-year estimate for the district health authorities in the catchment area taking the mid-years of two 5-year periods, 1986-1991 and 1992-1996 , from the Office for National Statistics. It was 3 158 058 for 1991 as the overall 10 year average. The 10 year population increase was only 61 694. The study area was the former Wessex Regional Health Authority and the Chichester District Health Authority.
Case ascertainment was by search of the histology department databases in the two hospitals with nephrologists serving this population. The hospitals are St Mary's Hospital, Portsmouth, which houses the Wessex Renal Unit, and Southampton General Hospital, a teaching hospital without chronic dialysis facilities. We searched for all cases of necrotizing and crescentic glomerulonephritis (NCGN ) without significant immune deposits suggesting a RPGN. Cases of lupus nephritis and Henoch-Schö nlein nephropathy were therefore excluded.
One hundred and forty one potential cases were identified of which 128 could be studied in detail. Six cases were untraceable, four were lost in a microfilm accident and three may have had their histology reviewed only, the patients not being clinically reviewed in Wessex. The age/sex profile of the missing patients was not significantly different. One hundred and twenty three patients were included in the incidence analysis. Five patients were excluded; four patients came from the Channel Islands and one from Somerset.
Data were collected from hospital records by a single investigator (N.H.) to achieve consistency.
The onset was defined as the start of symptoms suggestive of a vasculitic illness. To prevent confusion between vasculitic symptoms and other conditions co-morbidity was defined as any unrelated chronic illness present for at least 18 months and still active. Age was that given on the day of admission to the renal unit. Time to diagnosis was the time taken from the start of symptoms to reach a definitive diagnosis based on histology and serology. The involvement of other systems was defined as follows: (i) Upper airways: sinusitis, epistaxis, and nasal granuloma; (ii) lower airways: cough, haemoptysis, unexplained dyspnoea, pulmonary infiltrates and/or cavita-ANCA. Fourteen (11%) patients prior to 1988 had tion; (iii) joints: arthralgia or arthritis; (iv) muscle: myopathy positive ANCA before differentiation was made or myalgia; (v) skin: a vasculitic rash; (vi) nerves: peripheral between cANCA and pANCA. Thirty-five (27%) neuropathy and mononeuritis.
patients had negative ANCA despite repeat testing. ANCAs were assayed by direct immunofluorescence or by ANCA serology was assessed as strongly positive in ELISA, both validated tests [16 ] . ANCA serology was 58 (45%), moderately positive in 24 (19%) and weakly further divided after 1988 into the cytoplasmic staining positive in 9 patients (7%) (not recorded in two). More pattern (cANCA) and the peri-nuclear pattern (pANCA).
recently, as they became routinely available, ANCA
We defined recurrence as a re-appearance of the vasculitic sub-sets were looked for in 26 (20%); anti-proteinase process demonstrated by a rising creatinine, worsening proteinuria, an active urinary sediment or suggestive symptoms 3 was positive in five (4%), anti-myeloperoxidase in inexplicable by other diseases. Follow-up data were collected eight (6%) and anti-lactoferrin in one patient. No for a median of 1.8 years (range 0.9-9.64), the last date alive patient was HBsAg positive. Significantly, more cases either being the most recent clinic review or the date of death of co-morbidity were seen in the ANCA +ve group as given on the death certificate. Three (2%) patients were (P=0.03).
lost to follow up, having left the region.
Other auto-antibodies were found in 23 patients Data were analysed using SPSS, survival analysis by (18%); rheumatoid factor (RF ) in 12 (9%), antiKaplan-Meier and Cox's proportional hazards model. The nuclear antibodies (ANAs) in eight (6%) and one each x2 method and Mann-Whitney test for non-parametric variof gastric parietal call and thyroid. Four (3%) patients ables tested differences between the ANCA +ve and −ve were positive for both RF and ANA. Seven (5%) cases. Student's t-test was used for parametric variables.
patients had anti-glomerular basement membrane (GBM ) antibodies. None were strongly positive. They
Results
were proportionately distributed between ANCA +ve and ANCA −ve cases. Incidence
The annual average (with 95% confidence intervals) Treatment incidence rate for vasculitis with renal involvement in 1986-1996 was 3.9 patients per million (3.3-4.7). The
Most patients received combination therapy, usually rate was stable over time; the 5-year average rate for prednisolone (intravenous then oral ) with cyclophos-1986-1991 was 3.4 (2.2-4.4) and 4.4 (3.5-5.6) for phamide, which was later changed to azathioprine. 1991-1996.
Oral prednisolone was given to 123 (92%) patients, i.v. Incidence increased with age, 0.8 (0.4-1.6) for those methyl prednisolone to 102 (80%) patients, the median aged 18-39, 5.2 (3.7-7.1) aged 40-59 and 8.2 dose being 1.5 g (range 0.5-3 g, given over 3-5 days). (10.3-12.9) over 60 years.
Ninety-five (74%) patients received oral cyclophosGeographical variation in the overall incidence rate phamide, at a median dose of 1.5 mg/kg/day (range between the district health authorities ranged from 1.4 0.5-3). Thirty-eight (23%) patients received azathio-(0.7-2.6) to 8.7 (4.4-16.7) per million. This was not prine, the median dose being 1.5 mg/kg/day (range related to the proximity of a renal unit. 0.5-2), six (5%) receiving azathioprine at the start of their therapy, the remainder after a median (25th, 75th
Admission characteristics centile) of 69 (37-175) days of cyclophosphamide. Thirty-five (28%) severe cases had plasma exchange six (1-11) times over 10 (1-36) days. Exchange volume These are summarized in Table 2 .
Patients were predominantly referred from general was 3 l (2.5-4 l ) all figures are given as median (range). One patient received co-trimoxazole for active nasal medical units in other hospitals 91 (73%), by rheumatologists 11 (9%), respiratory physicians 6 (5%) and disease, another i.v. immunoglobulins for severe disease. general practitioners 17 (13%). Co-morbidity was observed in 60 (47%) patients. Cardiovascular disease Due to concurrent sepsis and/or cardiovascular collapse on arrival in the renal unit, five (4%) patients was present in 29 (23%), there were 12 (9%) cases of chronic inflammatory disease (five rheumatoid arth-had no immunosuppression, all died. These were all severely affected cases. ritis, three bronchiectasis, two ulcerative colitis, one chronic osteomyelitis of the leg and one of the spine), eight (6%) of respiratory disease, five (4%) patients
Prognosis and outcome
were hypothyroid. Neoplasia was present in four (3%), all solid tumours. In this group, the male: female ratio was not significant. Figure 1 charts the progress of the patients after their arrival on the renal unit. Of the 97 (76%) patients with urine output recorded on admission, 52 (41%) patients were oliguric or Fifty (39%) patients needed chronic renal replacement therapy (RRT ) as defined by the USRDS. anuric.
ANCA assay results were positive in 93 patients Allowing for death, transplantation and later RRT, this provided 2-3 patients per year for the dialysis (73%). Of these, 46 (36%) had the cytoplasmic staining pattern ANCA and 33 (26%) peri-nuclear staining programme, 1-2 patients per million population. eVasculitis also seen in three other patients, one nose, one spleen (at post-mortem) and one skin. fPeritoneal dialysis 9(7%) and continuous venous venous haemofiltration 1(0.8%).
There were 18 episodes of recurrence in 14 (11%) ANCA status, anaemia, number of glomeruli involved, type of treatment, time on dialysis, smoking, additional patients, nine (7%) of which needed hospitalization for a median of 5 days (range 2-22). The diagnosis was system involvement, infective episodes and patient source were all not significant. made clinically, supported by rising ANCA titres in 11 episodes, solely clinically in six episodes and in rapidly rising ANCA titres in one only.
Transplants
Complicating infections occurred in 46 (36%) with a mean of 1.6 episodes per patient (range 1-6), requiring hospital admission for a median of 14 days Thirteen (10%) patients received renal transplants. The median time from diagnosis to transplantation was (range 1-31).
Neutropenia (white cell count <2×109/l ) occurred 1.76 years (range 0.73-8.87). Transplanted patients were younger, mean age 51.0 vs 62.0 years (P=0.05). in 44 (34%). Reduction or cessation of immuno suppression was required in all cases, but five (4%) The median follow up post-transplant was 2.61 years (range 0.14-5.45) when the mean±SD serum creatinpatients died of sepsis. Figure 2 shows the Kaplan-Meier survival curves, ine concentration was 176.5±105 mmol/l. All transplants took place after 1990, limiting the follow up comparing those needing RRT with those who did not. Overall, 87 patients survived after 1 year (68%) period in this study. Three of the patients were ANCA -ve (not significant). At 1 year 92% of the patients of whom 75 (59%) were alive by the end of the study period. Of the 53 deaths, 18 had a post-mortem. The were alive. One patient died of surgical complications, the other 12 all had functioning grafts. No recurrent main cause of death, as registered in the Death Certificate, was: cardiovascular disease in 18 (14%); disease was seen. sepsis in 14 (11%); the underlying vasculitic illness in 11 (9%); gastro-intestinal complications in four (3%); Discussion and three (2%) each of neoplasia and miscellaneous.
On multivariate analysis increasing age and the need for dialysis (even for a short period) conferred a poor This is the largest reported population-based study of pauci-immune RPGN. It is the only one comparing prognosis (P=0.0004 and P=0.004 respectively). ANCA −ve with ANCA +ve small vessel vasculitis. odology was changing during this time and it was reliant on routine clinical notes. In contrast to previous studies [4, [8] [9] [10] [11] [12] [13] [14] ,21] we have included all patients from a defined population referred
The aetiology of vasculitis is obscure. Associations with silicone exposure, petrochemicals, parvovirus B19 for renal biopsy. The potential limitations of our study are that it was retrospective, the ANCA assay meth-and arboviruses have been made [20] . Although not designed to do so, and limited by its retrospective Interestingly, 12 (9%) of our patients had an underlying chronic inflammatory process raising the possibilnature, we were unable to demonstrate any aetiological features, in particular there were no occupational, ity that this could have been a trigger for the disease.
This has been noted [23] but needs to be studied geographical or temporal clusters.
Our incidence rate indicates that this is a rare further. All patients in this study had multi-system involvement predominantly with airway involvement, condition. We may have underestimated, as by using strict histological criteria our search method was highly no case of 'renal limited' disease was seen. This agrees with previous studies and indicates that pauci-immune specific but insensitive. Also, we only looked at cases referred to the regional Nephrology service. Cases RPGN is always part of a multisystem disorder [18, 19, 22] . seen elsewhere may have been undiagnosed and/or not referred. In addition there may have been cases, with
Avoidance of dialysis was a major predictor of survival. This confirms the need for early diagnosis mild renal involvement, treated by other specialists that did not receive a renal biopsy. and referral [3] . However, late referral to hospital appears normal. When patients are referred late, the Our overall figure of 4 cases per million population per year equated to one admission per month. Earlier more aggressive immunosuppression used and the severity of the underlying vasculitic process may result studies have suggested a rising incidence [15, 17] over time. However, in this study the small rise in incidence in more septic and cardiovascular complications [11] .
In this centre transplantation of patients with RPGN rate over the 10-year period was not statistically significant. began in 1990. Those transplanted were younger than the group as a whole. The results were excellent. No We saw less recurrence than some studies [3] . This may be explained by the unselected nature of the cases recurrence of vasculitis was seen. We believe that this is the largest group reported from a single centre. and differences between centres in the immunosuppressive regimes used. Also, compared to some This study has advanced the understanding of pauciimmune RPGN at a population level. It confirms the studies [24] , our follow-up period was relatively short. Late recurrence is well described in these conditions.
value of a population-based study in defining the clinical epidemiology of important conditions. We have In comparison with other series, our patients had more severe renal failure on referral and were older, demonstrated the need to treat ANCA −ve and ANCA +ve disease similarly. National prospective whereas the slight male predominance was similar. These differences probably reflect the unselected refer-studies/registries are needed if we are to gain a clearer understanding of the aetiology, clinical, serological and ral pattern and despite this, and the high proportion needing early dialysis, our survival figures are similar. histological correlations and outcome of these conditions. Estimating the onset was difficult because symptoms started insidiously. Patients were unwell for a median was frequent, the last interpretation seems unlikely.
